A study of DW1807 for year-round allergies and asthma
Treatments studied
Part of Ear, nose & throat, Immune system & allergy, Lungs & breathing clinical trials.
This trial tests a new medicine called DW1807 for people who have both year-round allergies (like dust mites or pet dander) and asthma. It aims to see if it helps control nasal symptoms and is safe to use.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 19 years or older.
- You have had year-round nasal allergies for at least 2 years.
- A skin or blood test in the past year shows you are allergic to something like dust mites, cats, or mold.
- You have asthma that is well-controlled with Step 2 to Step 4 treatments.
- Your average nasal symptom score over a week is 6 or higher out of 12.
- You have not had an asthma attack or a cold in the past few weeks.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new nasal spray for people with perennial (year-round) allergic rhinitis. It aims to see if the medicine works well and is safe compared to other treatments.
This trial tests if a special probiotic blend can help people with year-round allergic rhinitis (nasal allergies) caused by common indoor allergens like dust mites, cat, or dog dander. Volunteers will take the probiotic daily and track their symptoms.
This trial tests an under-the-tongue tablet for people with dust mite allergies causing moderate to severe nasal symptoms or mild-to-moderate asthma. The goal is to see if it improves symptoms and can replace or reduce the need for allergy medicines.
This study tests a new injection called JYB1904 for people with year-round nasal allergies. It may help reduce symptoms like sneezing, stuffy nose, and runny nose.
This trial tests if allergy shots (allergen-specific immunotherapy) can reduce symptoms of moderate to severe dust mite allergy. You will be in a room that exposes you to dust mites to see how well the treatment works, compared to a placebo.
This trial tests allergy drops placed under the tongue to treat allergic rhinitis caused by house dust mites. It aims to see if the drops can safely reduce symptoms like sneezing and stuffy nose.
Hear when a new Perennial Allergic Rhinitis Accompanied by Asthma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.